Initial clinical experience with a selective A2A receptor agonist, regadenoson, in a patient with end-stage renal disease on hemodialysis.
Laighold
Saaron
S
Division of Cardiology, North Shore University Hospital, Manhasset, USA.
Druz
Regina
R
D058917:Adenosine A2 Receptor Antagonists; D000328:Adult; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000000981:diagnostic imaging*; D017202:Myocardial Ischemia / Q000150:complications* / Q000000981:diagnostic imaging*; D010865:Pilot Projects; D011687:Purines; D011720:Pyrazoles; D011859:Radiography; D011877:Radionuclide Imaging
D058917:Adenosine A2 Receptor Antagonists; D011687:Purines; D011720:Pyrazoles; C430916:regadenoson